(Total Views: 626)
Posted On: 06/04/2022 5:45:23 AM
Post# of 156454
Re: KenChowder #124188
Thank you Ken for clearing that up. I forgot about this study, somehow I thought it had to do the mets to the brain.
If anyone knows how CytoDyn is pursuing metastasis to the brain in mTNBC, please say so.
I completely agree with you and ohm that pd-1 inhibitors are not necessary. mTNBC is the most virulent of the breast cancers and as we stand we have a documented 12.5 month OS. the best pd-1 inhibitor, paclitaxel and nab-paclitaxel only had a 6 month OS.
the side effects of the chemo do not warrant the benefits. it's a shame we need to tarnish this drug in combination therapy. This seems to be the only way though, at least in cancer, combination therapy.
If anyone knows how CytoDyn is pursuing metastasis to the brain in mTNBC, please say so.
I completely agree with you and ohm that pd-1 inhibitors are not necessary. mTNBC is the most virulent of the breast cancers and as we stand we have a documented 12.5 month OS. the best pd-1 inhibitor, paclitaxel and nab-paclitaxel only had a 6 month OS.
the side effects of the chemo do not warrant the benefits. it's a shame we need to tarnish this drug in combination therapy. This seems to be the only way though, at least in cancer, combination therapy.
(1)
(0)
